SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
CLDX Celldex Therapeudics
An SI Board Since September 2016
Posts SubjectMarks Bans Symbol
105 14 0 CLDX
Emcee:  Michael L Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
80 Hard to Borrow, Available to Short: 411,774 Sharewood_ny-6/11/2020
79wheeeeeeeeeeeeeeeeeeeeeee!!~~~~~~~~~~~~~~~~~scaram(o)uche-6/11/2020
78May be whoever hit the MEGA jackpot bought some CLDX for snacks :-) 3379 P2 estiwood_ny-6/10/2020
77Insiders bought shareswood_ny-6/10/2020
76why is stock up 70% today?Madharry-6/10/2020
75Great OS chart: drive.google.comwood_ny-6/7/2020
74DCM is another good target for 0159 Diffuse cutaneous mastocytosis (DCM) is sewood_ny-6/7/2020
73To reach pediatric population 0159 would need a loot of safety data (with evidenMiljenko Zuanic-6/7/2020
72Imatinib was used to treat Mast cell leukemia. Pts are very very rare. Rare Pediwood_ny-6/7/2020
71Wiki and Mast cell leukemia: en.wikipedia.org <Tumor markers[ edit]The leukemMiljenko Zuanic-6/6/2020
70Can CLDX get Rare Pediatric Disease Priority Review Voucher for Mast cell leukemwood_ny-6/6/2020
69Next step would be 250 mg subcutaneous re-formulation for further studies. For Miljenko Zuanic16/6/2020
68CDX-0159 Poster Presentation, P1-volunteers data (looking good): celldex.comMiljenko Zuanic-6/6/2020
67From ASCO poster, 80% pts with 2-4 lesions(n=16) still alive at 18 months aftewood_ny-5/31/2020
66Similar to Cohort II (guadecitabine, atezolizumab) in NCI cdx-1401 OC trial: Bawood_ny-5/26/2020
65FLT3 ligand (CDX-301) and stereotactic radiotherapy for advanced non-small cell wood_ny15/26/2020
64Did a fairly exhaustive search of ASCO abstract titles and didn't find anythscaram(o)uche-4/29/2020
63Cancers (Basel) 2020 Apr 22;12(4):E1026. doi: 10.3390/cancers12041026. Single Rscaram(o)uche-4/26/2020
62No relevance to current business plan. A cool trial, however, and look forward scaram(o)uche-4/15/2020
61here's another fun one, perhaps timely........ Cell Rep. 2020 Mar 17;30(11)scaram(o)uche-3/22/2020
60Population study MERTK Signalling in Monocytes/Macrophages in Patients With LivMiljenko Zuanic-3/17/2020
59With regard to the recent milestone payment from Rockefeller..... ir.celldex.coscaram(o)uche-3/16/2020
58<So happy that it worked for you, old buddy!> With your input and help ( :Miljenko Zuanic-2/23/2020
57So happy that it worked for you, old buddy! Sci Transl Med. 2019 Mar 13;11(483)scaram(o)uche-2/23/2020
56Rick, Thanks on all input on CLDX. Congret, cheers.Miljenko Zuanic-2/21/2020
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News